Yaşil S, Cömlekçi A, Güneri A
Dokuz Eylül University, Medical Faculty, Inciralti, Izmir, Turkey.
Postgrad Med J. 1998 Jun;74(872):363-4. doi: 10.1136/pgmj.74.872.363.
Ototoxicity is a rare and disabling complication in bisphosphonate therapy. Here we describe two patients who encountered further hearing loss during oral etidronate treatment for osteoporosis.
耳毒性是双膦酸盐治疗中一种罕见且致残的并发症。在此，我们描述两名在口服依替膦酸治疗骨质疏松症期间出现进一步听力损失的患者。
